Approximately 90% of individuals who stop taking injectable GLP-1 receptor agonists regain their lost weight within 15 months

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Supports users in reaching and maintaining a healthy body weight through behavioral and nutritional tools.